1,287
Views
95
CrossRef citations to date
0
Altmetric
Reviews

PIM1 kinase as a target for cancer therapy

, &
Pages 425-436 | Published online: 04 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Samdani Ansar & Umashankar Vetrivel. (2022) Structure-based design of small molecule and peptide inhibitors for selective targeting of ROCK1: an integrative computational approach. Journal of Biomolecular Structure and Dynamics 40:16, pages 7450-7468.
Read now
Ahmed E. M. Mekky, Sherif M. H. Sanad, Ahmed Y. Said & Mohamed A. A. Elneairy. (2020) Synthesis, cytotoxicity, in-vitro antibacterial screening and in-silico study of novel thieno[2,3-b]pyridines as potential pim-1 inhibitors. Synthetic Communications 50:15, pages 2376-2389.
Read now
Ran-ran Ding, Jian-ling Yuan, Ya-nan Jia, Xiao-min Liao, Si-si Wang, Zhong-ming Shao, Mu-yin Feng, Wei Jie & Zhi-hua Shen. (2019) Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation. OncoTargets and Therapy 12, pages 1137-1146.
Read now
Bassem H. Naguib, Hala B. El-Nassan & Tamer M. Abdelghany. (2017) Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 457-467.
Read now
Bassem H. Naguib & Hala B. El-Nassan. (2016) Synthesis of new thieno[2,3-b]pyridine derivatives as pim-1 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1718-1725.
Read now
Gubbi M Arunesh, Ekambaram Shanthi, Mudeenahally H Krishna, Jegatheesan Sooriya Kumar & Vellarkad N Viswanadhan. (2014) Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update. Expert Opinion on Therapeutic Patents 24:1, pages 5-17.
Read now
Naoko Ogawa, Hitomi Yuki & Akiko Tanaka. (2012) Insights from Pim1 structure for anti-cancer drug design. Expert Opinion on Drug Discovery 7:12, pages 1177-1192.
Read now

Articles from other publishers (88)

Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, Mahmoud A. Elrebehy, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Emad Gamil Khidr, Tohada M. AL-Noshokaty, Reem Khaled, Nehal I. Rizk, Mohammed S. Elballal, Ghadir A. Sayed, Mai A. Abd-Elmawla, Manar Mohammed El Tabaa, Osama A. Mohammed, Alaa Ashraf, Ahmed A. El-Husseiny, Heba M. Midan, Walaa A. El-Dakroury, Mustafa Ahmed Abdel-Reheim & Ahmed S. Doghish. (2023) Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma. Pathology - Research and Practice 252, pages 154947.
Crossref
K. Vedhapriya, G. Balaji, S. Sakthivel, Saleem Javed, M. Thirunavukkarasu & S. Muthu. (2023) Quantum Computational, Molecular structure interaction, Bonding, Spectral and Hiershfeld surface analysis of -2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-D-glucose-Anti-Hematologic cancer agent.. Chemical Physics Impact 7, pages 100262.
Crossref
Zhao Deng & Des R. Richardson. (2023) The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics. Pharmacological Reviews 75:5, pages 1007-1035.
Crossref
Xiao-Ping Pan, Bu-Ren Jiya, Feng Wang & Zhu Lan. (2023) Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis. World Journal of Gastrointestinal Oncology 15:8, pages 1400-1411.
Crossref
Kun Li, Yuanbo Xu, Jun Sun, Wei Zhang & Peizhi Ma. (2023) Design, Synthesis and Biological Evaluation of Novel Quinoline Derivatives as Potential Anti-Proliferative Agents Against PC-3 and KG-1 Cells. Anti-Cancer Agents in Medicinal Chemistry 23:5, pages 599-611.
Crossref
K. Vedhapriya, G. Balaji, B. Dhiyaneshwari, Ahmad Irfan, M. Thirunavukkarasu, S. Kaleeswaran, Safia Obairdur Rab & S. Muthu. (2023) Effect of green solvents, molecular structure and topological studies on 4-amino-1-β-d-ribofuranosyl-1,3,5 triazin-2(1H)-one - anti-blood cancer agent. Journal of the Indian Chemical Society 100:2, pages 100912.
Crossref
Hussien Ahmed Khamees, Mahesh Sankanahalli Srinivas, Omantheswara Nagaraja, Mahendra Madegowda, Vindu Vahini M, Kumara Chaluvaiah, Jagadeesh Prasad Dasappa & Ismail Warad. (2023) Studies on New Imidazo[2,1-b][1,3,4]thiadiazole Derivatives: Molecular Structure, Quantum Chemical Computational, and In silico Study of Inhibitory Activity Against Pim-1 Protein by using Molecular Modelling Methods and ADMET Profiling. Journal of Molecular Structure 1272, pages 134161.
Crossref
Yanwen Luo, Jiefu Zhu, Fan Zhao, Lang Shi, Yuzhen Li & Xiongfei Wu. (2023) PIM1 attenuates renal ischemia–reperfusion injury by inhibiting ASK1-JNK/P38. International Immunopharmacology 114, pages 109563.
Crossref
Ashley Y. Gao, Ana M. Diaz Espinosa, Fiorenza Gianì, Tho X. Pham, Chase M. Carver, Aja Aravamudhan, Colleen M. Bartman, Giovanni Ligresti, Nunzia Caporarello, Marissa J. Schafer & Andrew J. Haak. (2022) Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome. American Journal of Physiology-Lung Cellular and Molecular Physiology 323:6, pages L685-L697.
Crossref
Shaimaa M. Aboukhatwa, Amera O. Ibrahim, Hiroshi Aoyama, Ahmed S. Al-Behery, Moataz A. Shaldam, Ghada El-Ashmawy & Haytham O. Tawfik. (2022) Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition. Bioorganic Chemistry 129, pages 106126.
Crossref
Yang Gao, Weijia Xu, Chen Guo & Tao Huang. (2022) GATA1 regulates the microRNA‑328‑3p/PIM1 axis via circular RNA ITGB1 to promote renal ischemia/reperfusion injury in HK‑2 cells. International Journal of Molecular Medicine 50:2.
Crossref
Jing Huang, Ye Yuan, Xiaoxiao Zhu, Guodong Li, Ya Xu, Wenlin Chen & Ying Zhu. (2022) Identification of Pim-1 Kinase Inhibitors by Pharmacophore Model, Molecular Docking-based Virtual Screening, and Biological Evaluation. Current Computer-Aided Drug Design 18:3, pages 240-246.
Crossref
Shahid Iqbal, Waseeq Ahmad Siddiqui, Adnan Ashraf, Kelvin K.H. Tong, Farhana Aman, Tilo Söhnel, Stephen M.F. Jamieson, Muhammad Hanif & Christian G. Hartinger. (2022) Substitution of the chlorido ligand for PPh3 in anticancer organoruthenium complexes of sulfonamide-functionalized pyridine-2-carbothioamides leads to high cytotoxic activity. Inorganica Chimica Acta 536, pages 120889.
Crossref
Sutapa Mahata, Pranab K. Sahoo, Ranita Pal, Sinjini Sarkar, Tanuma Mistry, Sushmita Ghosh & Vilas D. Nasare. (2022) PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer. Medical Oncology 39:7.
Crossref
Ota Fuchs. 2022. Biotechnology in Healthcare. Biotechnology in Healthcare 71 88 .
L. J. Smyth, J. Kilner, V. Nair, H. Liu, E. Brennan, K. Kerr, N. Sandholm, J. Cole, E. Dahlström, A. Syreeni, R. M. Salem, R. G. Nelson, H. C. Looker, C. Wooster, K. Anderson, G. J. McKay, F. Kee, I. Young, D. Andrews, C. Forsblom, J. N. Hirschhorn, C. Godson, P. H. Groop, A. P. Maxwell, K. Susztak, M. Kretzler, J. C. Florez & A. J. McKnight. (2021) Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study. Clinical Epigenetics 13:1.
Crossref
Alaa Shafie, Shama Khan, Sagar Batra, Farah Anjum, Taj Mohammad, Shoaib Alam, Dharmendra Kumar Yadav, Asimul Islam & Md. Imtaiyaz Hassan. (2021) Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach. PLOS ONE 16:10, pages e0258929.
Crossref
William D.J. Tremlett, David M. Goodman, Tasha R. Steel, Saawan Kumar, Anna Wieczorek-Błauż, Fearghal P. Walsh, Matthew P. Sullivan, Muhammad Hanif & Christian G. Hartinger. (2021) Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands. Coordination Chemistry Reviews 445, pages 213950.
Crossref
Ahmed El Akkaoui, Jamal Koubachi, Gérald Guillaumet & Saïd El Kazzouli. (2021) Synthesis and Functionalization of Imidazo[1,2‐ b ]Pyridazine by Means of Metal‐Catalyzed Cross‐Coupling Reactions . ChemistrySelect 6:34, pages 8985-9011.
Crossref
Farah AnjumTaj Mohammad, Abdulraheem Ali AlmalkiOmar AkhtarBekhzod AbdullaevMd. Imtaiyaz Hassan. (2021) Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase. OMICS: A Journal of Integrative Biology 25:9, pages 580-590.
Crossref
Maria Musarra-Pizzo, Rosamaria Pennisi, Ichrak Ben-Amor, Giuseppina Mandalari & Maria Teresa Sciortino. (2021) Antiviral Activity Exerted by Natural Products against Human Viruses. Viruses 13:5, pages 828.
Crossref
Junpeng Xu, Peifeng Li, Jia Chai, Kangjie Yu, Tianqi Xu, Danhui Zhao, Yixiong Liu, Yingmei Wang, Kaijing Wang, Jing Ma, Linni Fan, Qingguo Yan, Shuangping Guo, Hualiang Xiao, Qilin Ao, Zhaoming Wang, Weiping Liu, Sha Zhao, Weihua Yin, Yuhua Huang, Yaqin Li, Miaoxia He, Rong Liang, Mingyang Li & Zhe Wang. (2021) The clinicopathological and molecular features of sinusoidal large B-cell lymphoma. Modern Pathology 34:5, pages 922-933.
Crossref
Prajwal Dhokne, Akash P. Sakla & Nagula Shankaraiah. (2021) Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances. European Journal of Medicinal Chemistry 216, pages 113334.
Crossref
Ota Fuchs & Radka Bokorova. (2021) Preclinical Studies of PROTACs in Hematological Malignancies. Cardiovascular & Hematological Disorders-Drug Targets 21:1, pages 7-22.
Crossref
Masatake Sugita, Itaru Onishi, Masayuki Irisa, Norio Yoshida & Fumio Hirata. (2021) Molecular Recognition and Self-Organization in Life Phenomena Studied by a Statistical Mechanics of Molecular Liquids, the RISM/3D-RISM Theory. Molecules 26:2, pages 271.
Crossref
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Pralay Das & Rituraj Purohit. (2021) Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants. Genomics 113:1, pages 707-715.
Crossref
Laila Baqlouq, Malek Zihlif, Hana Hammad & Tuqa M. Abu Thaib. (2020) Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different Cancer Cell Lines. Current Molecular Pharmacology 14:1, pages 52-59.
Crossref
Amel M. Farrag, Mona H. Ibrahim, Ahmed B.M. Mehany & Magda M.F. Ismail. (2020) New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study. Bioorganic Chemistry 105, pages 104378.
Crossref
Kaili Liu, Fei Zhao, Jingjing Yan, Zhengchao Xia, Dandan Jiang & Peizhi Ma. (2020) Hispidulin: A promising flavonoid with diverse anti-cancer properties. Life Sciences 259, pages 118395.
Crossref
Victor Sukbong Hong, Seungik Jeong, Yanghwan Yun, Hyeonseong Choo, Jongin Won & Jinho Lee. (2020) 1,3, 4‐Oxadiazole ‐2( 3 H )‐thione Analogs as PIM Kinase Inhibitors . Bulletin of the Korean Chemical Society 41:10, pages 994-1001.
Crossref
Sujin Kim, Wonki Kim, Do-Hee Kim, Jeong-Hoon Jang, Su-Jung Kim, Sin-Aye Park, Hyunggu Hahn, Byung Woo Han, Hye-Kyung Na, Kyung-Soo Chun, Bu Young Choi & Young-Joon Surh. (2020) Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity. Archives of Biochemistry and Biophysics 689, pages 108413.
Crossref
Qing Li, Leifeng Chen, Chen Luo, ChenYan, Jin Ge, Zhengming Zhu, Kai Wang, Xin Yu, Jun Lei, Tiande Liu, Xiaogang Peng, Xiuxia Liu & Rongfa Yuan. (2020) TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth. Experimental Cell Research 391:1, pages 111975.
Crossref
Takeshi Ashida & Takeshi Kikuchi. (2020) A new method for estimating the relative binding free energy, derived from a free energy variational principle for the Pim-1-kinase–ligand and FKBP–ligand systems. Journal of Computer-Aided Molecular Design 34:6, pages 647-658.
Crossref
Asmaa M. AboulMagd, Hossam M. Hassan, Ahmed M. Sayed, Usama Ramadan Abdelmohsen & Hamdy M. Abdel-Rahman. (2020) Saccharomonosporine A inspiration; synthesis of potent analogues as potential PIM kinase inhibitors. RSC Advances 10:12, pages 6752-6762.
Crossref
Xiuxiu Wang, Feng Chen, Jingyi Zhang, Jianxuan Sun, Xinyang Zhao, Yuelu Zhu, Wei Wei, Jing Zhao & Zijian Guo. (2019) A ferroptosis-inducing iridium(III) complex. Science China Chemistry 63:1, pages 65-72.
Crossref
Yangying Zhou, Zhijie Xu, Wei Lin, Yumei Duan, Can Lu, Wei Liu, Weiping Su, Yuanliang Yan, Huan Liu, Li Liu, Meizuo Zhong, Jianhua Zhou & Hong Zhu. (2019) Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. Frontiers in Oncology 9.
Crossref
Dujun Ma, Tian Yu, Liping Peng, Lixin Wang, Zhouwei Liao & Wenming Xu. (2019) PIM1, CYP1B1, and HSPA2 Targeted by Quercetin Play Important Roles in Osteoarthritis Treatment by Achyranthes bidentata . Evidence-Based Complementary and Alternative Medicine 2019, pages 1-10.
Crossref
Changwen Zhang, Yunkai Qie, Tong Yang, Li Wang, E Du, Yan Liu, Yong Xu, Baomin Qiao & Zhihong Zhang. (2019) Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress. Carcinogenesis 40:1, pages 52-60.
Crossref
Omer Faruk Karatas. (2018) Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1 . Head & Neck 40:11, pages 2455-2461.
Crossref
Yangying Zhou, Wei Liu, Zhijie Xu, Hong Zhu, Desheng Xiao, Weiping Su, Ruolan Zeng, Yuhua Feng, Yumei Duan, Jianhua Zhou & Meizuo Zhong. (2018) Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes. Neoplasia 20:10, pages 1059-1069.
Crossref
David A. Carlson, Miriam R. Singer, Cindy Sutherland, Clara Redondo, Leila T. Alexander, Philip F. Hughes, Stefan Knapp, Susan B. Gurley, Matthew A. Sparks, Justin A. MacDonald & Timothy A.J. Haystead. (2018) Targeting Pim Kinases and DAPK3 to Control Hypertension. Cell Chemical Biology 25:10, pages 1195-1207.e32.
Crossref
K. Chojnacki, P. Wińska, M. Wielechowska, E. Łukowska-Chojnacka, C. Tölzer, K. Niefind & M. Bretner. (2018) Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. Bioorganic Chemistry 80, pages 266-275.
Crossref
Holly Koblish, Yun-long Li, Niu Shin, Leslie Hall, Qian Wang, Kathy Wang, Maryanne Covington, Cindy Marando, Kevin Bowman, Jason Boer, Krista Burke, Richard Wynn, Alex Margulis, Gary W. Reuther, Que T. Lambert, Valerie Dostalik Roman, Ke Zhang, Hao Feng, Chu-Biao Xue, Sharon Diamond, Greg Hollis, Swamy Yeleswaram, Wenqing Yao, Reid Huber, Kris Vaddi & Peggy Scherle. (2018) Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies. PLOS ONE 13:6, pages e0199108.
Crossref
Charles E. de Bock, Sofie Demeyer, Sandrine Degryse, Delphine Verbeke, Bram Sweron, Olga Gielen, Roel Vandepoel, Carmen Vicente, Marlies Vanden Bempt, Antonis Dagklis, Ellen Geerdens, Simon Bornschein, Rik Gijsbers, Jean Soulier, Jules P. Meijerink, Merja Heinäniemi, Susanna Teppo, Maria Bouvy-Liivrand, Olli Lohi, Enrico Radaelli & Jan Cools. (2018) HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development. Cancer Discovery 8:5, pages 616-631.
Crossref
Alexey A. Panov, Alexander Yu. Simonov, Sergey N. Lavrenov, Sergey A. Lakatosh & Alexey S. Trenin. (2018) 3,4-Disubstituted maleimides: synthesis and biological activity. Chemistry of Heterocyclic Compounds 54:2, pages 103-113.
Crossref
Takeshi Hasegawa, Masatake Sugita, Takeshi Kikuchi & Fumio Hirata. (2017) A Systematic Analysis of the Binding Affinity between the Pim-1 Kinase and Its Inhibitors Based on the MM/3D-RISM/KH Method. Journal of Chemical Information and Modeling 57:11, pages 2789-2798.
Crossref
Po-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, Pei-Yu Chen, Ya-Hui Huang, Chau-Ting Yeh, Chia-Siu Wang & Kwang-Huei Lin. (2017) Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214. Scientific Reports 7:1.
Crossref
Keke Wang, Xiaojiang Deng, Zhihua Shen, Yanan Jia, Ranran Ding, Rujia Li, Xiaomin Liao, Sisi Wang, Yanping Ha, Yueqiong Kong, Yuyou Wu, Junli Guo & Wei Jie. (2017) High glucose promotes vascular smooth muscle cell proliferation by upregulating proto-oncogene serine/threonine-protein kinase Pim-1 expression. Oncotarget 8:51, pages 88320-88331.
Crossref
Carole J.R. Bataille, Méabh B. Brennan, Simon Byrne, Stephen G. Davies, Matthew Durbin, Oleg Fedorov, Kilian V.M. Huber, Alan M. Jones, Stefan Knapp, Gu Liu, Anna Nadali, Camilo E. Quevedo, Angela J. Russell, Roderick G. Walker, Robert Westwood & Graham M. Wynne. (2017) Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family. Bioorganic & Medicinal Chemistry 25:9, pages 2657-2665.
Crossref
Manuel Pedro Jiménez-García, Antonio Lucena-Cacace, María José Robles-Frías, Maja Narlik-Grassow, Carmen Blanco-Aparicio & Amancio Carnero. (2016) The role of PIM1/PIM2 kinases in tumors of the male reproductive system. Scientific Reports 6:1.
Crossref
Xiao-xu Wang, Jue Liu, Yi-min Tang, Liang Hong, Zhi Zeng & Guang-hua Tan. (2017) MicroRNA-638 inhibits cell proliferation by targeting suppress PIM1 expression in human osteosarcoma. Tumor Biology 37:12, pages 16367-16375.
Crossref
Ryan P. Wurz, Christine Sastri, Derin C. D’Amico, Brad Herberich, Claire L.M. Jackson, Liping H. Pettus, Andrew S. Tasker, Bin Wu, Nadia Guerrero, J. Russell Lipford, Jeffrey T. Winston, Yajing Yang, Paul Wang, Yen Nguyen, Kristin L. Andrews, Xin Huang, Matthew R. Lee, Christopher Mohr, J.D. Zhang, Darren L. Reid, Yang Xu, Yihong Zhou & Hui-Ling Wang. (2016) Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 26:22, pages 5580-5590.
Crossref
Goodwin G. Jinesh, Sharada Mokkapati, Keyi Zhu & Edwin E. Morales. (2016) Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks. Apoptosis 21:11, pages 1203-1213.
Crossref
Makaram M. Said, Azza T. Taher, Hala B. El-Nassan & Eman A. El-Khouly. (2016) Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents. Research on Chemical Intermediates 42:8, pages 6643-6662.
Crossref
Liping H. Pettus, Kristin L. Andrews, Shon K. Booker, Jie Chen, Victor J. Cee, Frank ChavezJr.Jr., Yuping Chen, Heather Eastwood, Nadia Guerrero, Bradley Herberich, Dean Hickman, Brian A. Lanman, Jimmy LaszloIIIIII, Matthew R. Lee, J. Russell Lipford, Bethany Mattson, Christopher Mohr, Yen Nguyen, Mark H. Norman, David Powers, Anthony B. Reed, Karen Rex, Christine Sastri, Nuria Tamayo, Paul Wang, Jeffrey T. Winston, Bin Wu, Tian Wu, Ryan P. Wurz, Yang Xu, Yihong Zhou, Andrew S. Tasker & Hui-Ling Wang. (2016) Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors. Journal of Medicinal Chemistry 59:13, pages 6407-6430.
Crossref
Kun Li, Ying Li, Di Zhou, Yinbo Fan, Hongye Guo, Tianyi Ma, Jiachen Wen, Dan Liu & Linxiang Zhao. (2016) Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors. Bioorganic & Medicinal Chemistry 24:8, pages 1889-1897.
Crossref
Yin-Bo Fan, Kun Li, Min Huang, Yu Cao, Ying Li, Shu-Yu Jin, Wen-Bing Liu, Jia-Chen Wen, Dan Liu & Lin-Xiang Zhao. (2016) Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 26:4, pages 1224-1228.
Crossref
YINGQIU XIE & SAMAT BAYAKHMETOV. (2016) PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells. Molecular and Clinical Oncology 4:1, pages 13-17.
Crossref
Lucia Mazzacurati, Que T. Lambert, Anuradha Pradhan, Lori N. Griner, Dennis Huszar & Gary W. Reuther. (2015) The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget 6:37, pages 40141-40157.
Crossref
Isolda Romero-Canelón, Ben Phoenix, Anaïs Pitto-Barry, Johanna Tran, Joan J. Soldevila-Barreda, Nigel Kirby, Stuart Green, Peter J. Sadler & Nicolas P.E. Barry. (2015) Arene ruthenium dithiolato–carborane complexes for boron neutron capture therapy (BNCT). Journal of Organometallic Chemistry 796, pages 17-25.
Crossref
Huiyong Hu, Xiaojing Wang, Grace Ka Yan Chan, Jae H. Chang, Steven Do, Jake Drummond, Allen Ebens, Wendy Lee, Justin Ly, Joseph P. Lyssikatos, Jeremy Murray, John G. Moffat, Qi Chao, Vickie Tsui, Heidi Wallweber & Aleksandr Kolesnikov. (2015) Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. Bioorganic & Medicinal Chemistry Letters 25:22, pages 5258-5264.
Crossref
Sabine Hünten, Markus Kaller, Friedel Drepper, Silke Oeljeklaus, Thomas Bonfert, Florian Erhard, Anne Dueck, Norbert Eichner, Caroline C. Friedel, Gunter Meister, Ralf Zimmer, Bettina Warscheid & Heiko Hermeking. (2015) p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses. Molecular & Cellular Proteomics 14:10, pages 2609-2629.
Crossref
Zhong-Jian Shen, Jie Hu, Stephane Esnault, Igor Dozmorov & James S. Malter. (2015) RNA Seq profiling reveals a novel expression pattern of TGF-β target genes in human blood eosinophils. Immunology Letters 167:1, pages 1-10.
Crossref
Rajathees Rajaratnam, Elisabeth K. Martin, Markus Dörr, Klaus Harms, Angela CasiniEric Meggers. (2015) Correlation between the Stereochemistry and Bioactivity in Octahedral Rhodium Prolinato Complexes. Inorganic Chemistry 54:16, pages 8111-8120.
Crossref
Ryan P. Wurz, Liping H. Pettus, Claire Jackson, Bin Wu, Hui-Ling Wang, Brad Herberich, Victor Cee, Brian A. Lanman, Anthony B. Reed, Frank ChavezJr.Jr., Thomas Nixey, Jimmy LaszloIIIIII, Paul Wang, Yen Nguyen, Christine Sastri, Nadia Guerrero, Jeff Winston, J. Russell Lipford, Matthew R. Lee, Kristin L. Andrews, Christopher Mohr, Yang Xu, Yihong Zhou, Darren L. Reid & Andrew S. Tasker. (2015) The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 25:4, pages 847-855.
Crossref
Mark A. Wade, Dominic Jones, Laura Wilson, Jacqueline Stockley, Kelly Coffey, Craig N. Robson & Luke Gaughan. (2015) The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Research 43:1, pages 196-207.
Crossref
Bich Thuy Le, Malika Kumarasiri, Julian RJ Adams, Mingfeng Yu, Robert Milne, Matthew J Sykes & Shudong Wang. (2015) Targeting Pim kinases for cancer treatment: opportunities and challenges. Future Medicinal Chemistry 7:1, pages 35-53.
Crossref
Cristina Girardi, Daniele Ottaviani, Lorenzo A. Pinna & Maria Ruzzene. (2015) Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB. BioMed Research International 2015, pages 1-9.
Crossref
Beata Kalatova, Renata Jesenska, Daniel Hlinka & Marek Dudas. (2015) Tripolar mitosis in human cells and embryos: Occurrence, pathophysiology and medical implications. Acta Histochemica 117:1, pages 111-125.
Crossref
Lisa S. Chen & Varsha Gandhi. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia 177 199 .
Vikash Kumar, Saman Khan, Priyanka Gupta, Namrata Rastogi, Durga Prasad Mishra, Shakil Ahmed & Mohammad Imran Siddiqi. (2014) Identification of novel inhibitors of human Chk1 using pharmacophore-based virtual screening and their evaluation as potential anti-cancer agents. Journal of Computer-Aided Molecular Design 28:12, pages 1247-1256.
Crossref
Hanzi Sun, Lifeng Zhao, Shiming Peng & Niu Huang. (2014) Incorporating replacement free energy of binding-site waters in molecular docking. Proteins: Structure, Function, and Bioinformatics 82:9, pages 1765-1776.
Crossref
Jinho Lee, Kunal N. More, Seun-Ah Yang & Victor S. Hong. (2014) 3,5-Bis(aminopyrimidinyl)indole Derivatives: Synthesis and Evaluation of Pim Kinase Inhibitory Activities. Bulletin of the Korean Chemical Society 35:7, pages 2123-2129.
Crossref
Shih-Min A. Huang, Anlai Wang, Rita Greco, Zhifang Li, Fangxian Sun, Claude Barberis, Michel Tabart, Vinod Patel, Laurent Schio, Raelene Hurley, Bo Chen, Hong Cheng, Christoph Lengauer, Jack Pollard, James Watters, Carlos Garcia-Echeverria, Dmitri Wiederschain, Francisco Adrian & JingXin Zhang. (2014) Combination of PIM and JAK2 inhibitors synergistically suppresses cell proliferation and overcomes drug resistance of myeloproliferative neoplasms. Oncotarget 5:10, pages 3362-3374.
Crossref
Mingfeng Shao, Yiming Yuan, Kun Yu, Kai Lei, Guonian Zhu, Lijuan Chen & Mingli Xiang. (2014) Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach. Molecular Diversity 18:2, pages 335-344.
Crossref
Jianwei Xu, Taiping Zhang, Tianxiao Wang, Lei You & Yupei Zhao. (2014) PIM kinases: an overview in tumors and recent advances in pancreatic cancer. Future Oncology 10:5, pages 865-876.
Crossref
David A. Fruman & Christian Rommel. (2014) PI3K and cancer: lessons, challenges and opportunities. Nature Reviews Drug Discovery 13:2, pages 140-156.
Crossref
Francesco Casuscelli, Elena Ardini, Nilla Avanzi, Elena Casale, Giovanni Cervi, Matteo D’Anello, Daniele Donati, Daniela Faiardi, Ronald D. Ferguson, Gianpaolo Fogliatto, Arturo Galvani, Aurelio Marsiglio, Danilo G. Mirizzi, Marisa Montemartini, Christian Orrenius, Gianluca Papeo, Claudia Piutti, Barbara Salom & Eduard R. Felder. (2013) Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases. Bioorganic & Medicinal Chemistry 21:23, pages 7364-7380.
Crossref
Yan Liu, Beilei Zhao, Guangmei Mao, Xi Fang, Yahan Liu, Yu Huang & Nanping Wang. (2013) Epigallocatechin-3-O-Gallate, a Green Tea Polyphenol, Induces Expression of Pim-1 Kinase Via PPARγ in Human Vascular Endothelial Cells. Cardiovascular Toxicology 13:4, pages 391-395.
Crossref
Kathrin Wähler, Katja Kräling, Holger Steuber & Eric Meggers. (2013) Non-ATP-Mimetic Organometallic Protein Kinase Inhibitor. ChemistryOpen 2:5-6, pages 180-185.
Crossref
Mingzhang Gao, Min Wang, Kathy D. Miller & Qi-Huang Zheng. (2013) Synthesis of (Z)-2-((1H-indazol-3-yl)methylene)-6-[11C]methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one as a new potential PET probe for imaging of the enzyme PIM1. Bioorganic & Medicinal Chemistry Letters 23:15, pages 4342-4346.
Crossref
Sang Jae Lee, Byeong-Gu Han, Jea-Won Cho, Jang-Sik Choi, Jaekyoo Lee, Ho-Juhn Song, Jong Sung Koh & Byung Il Lee. (2013) Crystal Structure of Pim1 Kinase in Complex with a Pyrido[4,3-D]Pyrimidine Derivative Suggests a Unique Binding Mode. PLoS ONE 8:7, pages e70358.
Crossref
Xiaojing Wang, Steven Magnuson, Rich Pastor, Eric Fan, Huiyong Hu, Vickie Tsui, Wei Deng, Jeremy Murray, Micah Steffek, Heidi Wallweber, John Moffat, Jason Drummond, Grace Chan, Eric Harstad & Allen J. Ebens. (2013) Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3149-3153.
Crossref
Wanyeon Kim, HyeSook Youn, TaeWoo Kwon, JiHoon Kang, EunGi Kim, Beomseok Son, Hee Jung Yang, Youngmi Jung & BuHyun Youn. (2013) PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells. Pharmacological Research 70:1, pages 90-101.
Crossref
Mattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, Marco Radi, Silvia Schenone, Francesca Musumeci, Chiara Brullo, Patrizia Sanità, Simona Delle Monache, Adriano Angelucci, Miroslava Kissova, Emmanuele Crespan, Giovanni Maga & Maurizio Botta. (2013) A Combination Strategy to Inhibit Pim-1: Synergism between Noncompetitive and ATP-Competitive Inhibitors. ChemMedChem 8:3, pages 484-496.
Crossref
Nicolas P. E. Barry & Peter J. Sadler. (2013) Exploration of the medical periodic table: towards new targets. Chemical Communications 49:45, pages 5106.
Crossref
Jun Yin, Lisa Shine, Francis Raycroft, Sudhakar Deeti, Alison Reynolds, Kristin M. Ackerman, Antonino Glaviano, Sean O'Farrell, Olivia O'Leary, Claire Kilty, Ciaran Kennedy, Sarah McLoughlin, Megan Rice, Eileen Russell, Desmond G. Higgins, David R. Hyde & Breandan N. Kennedy. (2012) Inhibition of the Pim1 Oncogene Results in Diminished Visual Function. PLoS ONE 7:12, pages e52177.
Crossref
Chris JoplingGuillermo SuñéAdèle FaucherreCarme FabregatJuan Carlos Izpisua Belmonte. (2012) Hypoxia Induces Myocardial Regeneration in Zebrafish. Circulation 126:25, pages 3017-3027.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.